Bayer IR Newsfeed: EventsBayer IR Newsfeed: Investor News16.09.08: Bayer HealthCare acquires German DIREVO Biotech AG- September 16, 2008 Bayer HealthCare acquires German DIREVO Biotech AG A recognized leader in protein engineering Expanding technological know-how in biologicals Strengthening Bayer HealthCare's commitment to develop innovative biologicalsmehr ...http://www.investor.bayer.de/no_cache/en/news/investor-news/investor-news/showNewsItem/996 16.09.08: Venous Blood Clot Prevention after Elective Total Knee and Hip Replacement Surgery:- September 16, 2008 Bayer's Xarelto Approved in CanadaFirst approval for Bayer's new oral, once-daily anticoagulant Marketing to start immediately First-in-class product to demonstrate superior efficacy to standard of care Most studied oral, direct Factor Xa inhibitor in the world todaymehr ...http://www.investor.bayer.de/no_cache/en/news/investor-news/investor-news/showNewsItem/994 08.09.08: New low-dose oral contraceptive YAZ launched in Europe- September 8, 2008 New low-dose oral contraceptive YAZ launched in Europe 244 dosing regimen has shown to reduce hormone fluctuations mehr ...http://www.investor.bayer.de/no_cache/en/news/investor-news/investor-news/showNewsItem/992 04.09.08: Setting the course after a very successful first half of 2008:- September 4, 2008 Bayer CropScience plans investment of EUR 3.4 billion in research and development through 2012Expansion of R&D program will strengthen basis for future growth Achievement of target EBITDA margin of around 25 percent already expected in 2008 Sales target of EUR 2 billion with new active ingredients now envisaged for 2009 Launch of 10 new crop protection compounds with a peak sales potential of more than EUR 1 billion planned through 2012mehr ...http://www.investor.bayer.de/no_cache/en/news/investor-news/investor-news/showNewsItem/990 02.09.08: Bayer Submits Recombinant Human Thrombin for European Approval- September 2, 2008 Bayer Submits Recombinant Human Thrombin for European ApprovalRecothrom would be the first recombinant human thrombin for use as a topical aid to surgical hemostasis in Europemehr ...http://www.investor.bayer.de/no_cache/en/news/investor-news/investor-news/showNewsItem/988 |